COMPANIES COVERED
Synthon PharmaceuticalsDownload FREE Report Sample
Download Free sampleBiosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
Remicade Biosimilar Market contains market size and forecasts of Remicade Biosimilar in global, including the following market information:
Global Remicade Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Remicade Biosimilar Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Remicade Biosimilar companies in 2021 (%)
The global Remicade Biosimilar market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100mg/10ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Remicade Biosimilar include Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc. and Genentech (Roche Group), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Remicade Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Remicade Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Remicade Biosimilar Market Segment Percentages, by Type, 2021 (%)
100mg/10ml
500mg/50ml
Global Remicade Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Remicade Biosimilar Market Segment Percentages, by Application, 2021 (%)
Blood Disorders
Oncology Diseases
Global Remicade Biosimilar Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Remicade Biosimilar Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Remicade Biosimilar revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Remicade Biosimilar revenues share in global market, 2021 (%)
Key companies Remicade Biosimilar sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Remicade Biosimilar sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
